Stratford’s Kubtec debuts 3D breast cancer surgery technology

Kubtec, a Stratford-based specimen imaging company, has introduced the Mozart iQ 3D Margin Management System as its latest advancement in breast cancer surgery.

According to the company, the new product utilizes amorphous selenium direct capture imaging technology as well as 3D intraoperative tomosynthesis X-ray technology, to provide breast surgeons an exceptionally clear view of surgical margins in the operating room. The product was introduced at the recent American Society of Breast Surgeons Annual Meeting and is exclusively available in the U.S. and Canada.

“At Kubtec, our mission is to empower precision surgery by providing surgeons with the best intraoperative technology,” said Vikram Butani, Kubtec CEO. “We are continually innovating and adding value to our products. The Mozart iQ, with its crisp, high-quality images, combined with the proven benefits of 3D tomosynthesis technology, represents a major advancement in intraoperative specimen imaging.”